Moreover, we verified lower TNFRSF1A expression levels in breast cancer patients compared to normal breast tissues (from TCGA and in another private cohort, Fig. 1F) and this reduced TNFRSF1A correlated with a worse prognosis (Fig. 1I), which demonstrate the potential translational relevance of our observations. This evidence concerns the gene TNFRSF1A and breast carcinoma.